Xencor (XNCR) EPS (Basic) Growth (1y) (2014 - 2026)
Xencor (XNCR) EPS (Basic) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 88.81% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 143.95% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -99.90% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -16.29% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 322.67% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 96.41% |
| 10 | Xencor | 1.73 Bn | 1.36 Bn | - | 30.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.90% |
| Mar 31, 2026 | -159.38% |
| Dec 31, 2025 | 87.38% |
| Sep 30, 2025 | 89.07% |
| Jun 30, 2025 | 62.79% |
| Mar 31, 2025 | 45.44% |
| Dec 31, 2024 | -63.35% |
| Sep 30, 2024 | -85.10% |
| Jun 30, 2024 | 6.20% |
| Mar 31, 2024 | -23.57% |
| Dec 31, 2023 | -115.41% |
| Sep 30, 2023 | 27.02% |
| Jun 30, 2023 | -108.46% |
| Mar 31, 2023 | -346.73% |
| Dec 31, 2022 | -116.13% |
| Sep 30, 2022 | 20.36% |
| Jun 30, 2022 | -163.59% |
| Mar 31, 2022 | 1,026.17% |
| Dec 31, 2021 | 622.98% |
| Sep 30, 2021 | -214.29% |